<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-05-01" modified="2017-12-20" version="176">
<accession>P21549</accession>
<accession>Q53QU6</accession>
<name>SPYA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine--pyruvate aminotransferase</fullName>
<shortName>SPT</shortName>
<ecNumber>2.6.1.51</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Alanine--glyoxylate aminotransferase</fullName>
<shortName>AGT</shortName>
<ecNumber>2.6.1.44</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary">AGXT</name>
<name type="synonym">AGT1</name>
<name type="synonym">SPAT</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Eur. J. Biochem." volume="194" first="9" last="18">
<title>Cloning and nucleotide sequence of cDNA encoding human liver serine-pyruvate aminotransferase.</title>
<authorList>
<person name="Nishiyama K."/>
<person name="Berstein G."/>
<person name="Oda T."/>
<person name="Ichiyama A."/>
</authorList>
<dbReference type="PubMed" id="2253628"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1990.tb19420.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="J. Cell Biol." volume="111" first="2341" last="2351">
<title>Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1.</title>
<authorList>
<person name="Purdue P.E."/>
<person name="Takada Y."/>
<person name="Danpure C.J."/>
</authorList>
<dbReference type="PubMed" id="1703535"/>
<dbReference type="DOI" id="10.1083/jcb.111.6.2341"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS LEU-11 AND MET-340</scope>
<scope>VARIANT HP1 ARG-170</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1990" name="Biochem. J." volume="268" first="517" last="520">
<title>Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon.</title>
<authorList>
<person name="Takada Y."/>
<person name="Kaneko N."/>
<person name="Esumi H."/>
<person name="Purdue P.E."/>
<person name="Danpure C.J."/>
</authorList>
<dbReference type="PubMed" id="2363689"/>
<dbReference type="DOI" id="10.1042/bj2680517"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1991" name="Genomics" volume="10" first="34" last="42">
<title>Characterization and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase.</title>
<authorList>
<person name="Purdue P.E."/>
<person name="Lumb M.J."/>
<person name="Fox M."/>
<person name="Griffo G."/>
<person name="Hamon-Benais C."/>
<person name="Povey S."/>
<person name="Danpure C.J."/>
</authorList>
<dbReference type="PubMed" id="2045108"/>
<dbReference type="DOI" id="10.1016/0888-7543(91)90481-S"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-9</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="J. Mol. Biol." volume="331" first="643" last="652">
<title>Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1.</title>
<authorList>
<person name="Zhang X."/>
<person name="Roe S.M."/>
<person name="Hou Y."/>
<person name="Bartlam M."/>
<person name="Rao Z."/>
<person name="Pearl L.H."/>
<person name="Danpure C.J."/>
</authorList>
<dbReference type="PubMed" id="12899834"/>
<dbReference type="DOI" id="10.1016/S0022-2836(03)00791-5"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL PHOSPHATE AND AMINO-OXYACETIC ACID</scope>
<scope>SUBUNIT</scope>
<scope>PYRIDOXAL PHOSPHATE AT LYS-209</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1991" name="Biochem. Biophys. Res. Commun." volume="176" first="1093" last="1099">
<title>Primary hyperoxaluria type I due to a point mutation of T to C in the coding region of the serine:pyruvate aminotransferase gene.</title>
<authorList>
<person name="Nishiyama K."/>
<person name="Funai T."/>
<person name="Katafuchi R."/>
<person name="Hattori F."/>
<person name="Onoyama K."/>
<person name="Ichiyama A."/>
</authorList>
<dbReference type="PubMed" id="2039493"/>
<dbReference type="DOI" id="10.1016/0006-291X(91)90396-O"/>
</citation>
<scope>VARIANT HP1 PRO-205</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1992" name="Genomics" volume="13" first="215" last="218">
<title>A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity in a subset of patients with primary hyperoxaluria type 1.</title>
<authorList>
<person name="Purdue P.E."/>
<person name="Lumb M.J."/>
<person name="Allsop J."/>
<person name="Minatogawa Y."/>
<person name="Danpure C.J."/>
</authorList>
<dbReference type="PubMed" id="1349575"/>
<dbReference type="DOI" id="10.1016/0888-7543(92)90225-H"/>
</citation>
<scope>VARIANT HP1 GLU-82</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1992" name="Hum. Mol. Genet." volume="1" first="643" last="644">
<title>A serine-to-phenylalanine substitution leads to loss of alanine:glyoxylate aminotransferase catalytic activity and immunoreactivity in a patient with primary hyperoxaluria type 1.</title>
<authorList>
<person name="Minatogawa Y."/>
<person name="Tone S."/>
<person name="Allsop J."/>
<person name="Purdue P.E."/>
<person name="Takada Y."/>
<person name="Danpure C.J."/>
<person name="Kido R."/>
</authorList>
<dbReference type="PubMed" id="1301173"/>
<dbReference type="DOI" id="10.1093/hmg/1.8.643"/>
</citation>
<scope>VARIANT HP1 PHE-187</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1993" name="Am. J. Hum. Genet." volume="53" first="417" last="432">
<title>Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.</title>
<authorList>
<person name="Danpure C.J."/>
<person name="Purdue P.E."/>
<person name="Fryer P."/>
<person name="Griffiths S."/>
<person name="Allsop J."/>
<person name="Lumb M.J."/>
<person name="Guttridge K.M."/>
<person name="Jennings P.R."/>
<person name="Scheinman J.I."/>
<person name="Mauer S.M."/>
<person name="Davidson N.O."/>
</authorList>
<dbReference type="PubMed" id="8101040"/>
</citation>
<scope>VARIANTS HP1 ARG-41 AND ILE-152</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1993" name="Biochimie" volume="75" first="309" last="315">
<title>Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase.</title>
<authorList>
<person name="Danpure C.J."/>
</authorList>
<dbReference type="PubMed" id="8507692"/>
<dbReference type="DOI" id="10.1016/0300-9084(93)90091-6"/>
</citation>
<scope>REVIEW ON HP1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1997" name="J. Med. Genet." volume="34" first="489" last="492">
<title>Primary hyperoxaluria type 1: a cluster of new mutations in exon 7 of the AGXT gene.</title>
<authorList>
<person name="von Schnakenburg C."/>
<person name="Rumsby G."/>
</authorList>
<dbReference type="PubMed" id="9192270"/>
<dbReference type="DOI" id="10.1136/jmg.34.6.489"/>
</citation>
<scope>VARIANTS HP1 CYS-233; HIS-233 AND THR-244</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="J. Nephrol." volume="11" first="15" last="17">
<title>Identification of new mutations in primary hyperoxaluria type 1 (PH1).</title>
<authorList>
<person name="von Schnakenburg C."/>
<person name="Rumsby G."/>
</authorList>
<dbReference type="PubMed" id="9604803"/>
</citation>
<scope>VARIANTS HP1 ARG-108; TYR-173; ARG-190; ALA-296 DEL AND ASP-350</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Hum. Genet." volume="104" first="441" last="441">
<title>Gene symbol: AGXT. Disease: primary hyperoxaluria type I.</title>
<authorList>
<person name="Amoroso A."/>
<person name="Pirulli D."/>
<person name="Puzzer D."/>
<person name="Ferri L."/>
<person name="Crovella S."/>
<person name="Ferrettini C."/>
<person name="Marangella M."/>
<person name="Mazzola G."/>
<person name="Florian F."/>
</authorList>
<dbReference type="PubMed" id="10394939"/>
<dbReference type="DOI" id="10.1007/s004390050984"/>
</citation>
<scope>VARIANTS HP1 VAL-41; GLU-95 INS; ARG-116 AND ARG-156</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1999" name="Hum. Genet." volume="104" first="523" last="525">
<title>Molecular analysis of hyperoxaluria type 1 in Italian patients reveals eight new mutations in the alanine: glyoxylate aminotransferase gene.</title>
<authorList>
<person name="Pirulli D."/>
<person name="Puzzer D."/>
<person name="Ferri L."/>
<person name="Crovella S."/>
<person name="Amoroso A."/>
<person name="Ferrettini C."/>
<person name="Marangella M."/>
<person name="Mazzola G."/>
<person name="Florian F."/>
</authorList>
<dbReference type="PubMed" id="10453743"/>
<dbReference type="DOI" id="10.1007/s004390050998"/>
</citation>
<scope>VARIANTS HP1 VAL-41; GLU-95 INS; ARG-116 AND ARG-156</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="J. Am. Soc. Nephrol." volume="10" first="2352" last="2358">
<title>Primary hyperoxaluria type I: a model for multiple mutations in a monogenic disease within a distinct ethnic group.</title>
<authorList>
<person name="Rinat C."/>
<person name="Wanders R.J.A."/>
<person name="Drukker A."/>
<person name="Halle D."/>
<person name="Frishberg Y."/>
</authorList>
<dbReference type="PubMed" id="10541294"/>
</citation>
<scope>VARIANTS HP1 ARG-41; ARG-156; ARG-190; THR-244; CYS-289 AND PRO-298</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="577" last="577">
<title>Identification of 5 novel mutations in the AGXT gene.</title>
<authorList>
<person name="Basmaison O."/>
<person name="Rolland M.-O."/>
<person name="Cochat P."/>
<person name="Bozon D."/>
</authorList>
<dbReference type="PubMed" id="10862087"/>
<dbReference type="DOI" id="10.1002/1098-1004(200006)15:6&lt;577::AID-HUMU9>3.0.CO;2-#"/>
</citation>
<scope>VARIANTS HP1 ILE-152; ARG-170; ASN-183; CYS-233 AND THR-244</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="36415" last="36422">
<title>Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.</title>
<authorList>
<person name="Lumb M.J."/>
<person name="Danpure C.J."/>
</authorList>
<dbReference type="PubMed" id="10960483"/>
<dbReference type="DOI" id="10.1074/jbc.M006693200"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS HP1 ARG-41; GLU-82; ILE-152; ARG-170 AND THR-244</scope>
<scope>CHARACTERIZATION OF VARIANT LEU-11</scope>
<scope>MUTAGENESIS OF LYS-209</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Mol. Genet. Metab." volume="78" first="44" last="50">
<title>The AGT gene in Africa: a distinctive minor allele haplotype, a polymorphism (V326I), and a novel PH1 mutation (A112D) in Black Africans.</title>
<authorList>
<person name="Coulter-Mackie M.B."/>
<person name="Tung A."/>
<person name="Henderson H.E."/>
<person name="Toone J.R."/>
<person name="Applegarth D.A."/>
</authorList>
<dbReference type="PubMed" id="12559847"/>
<dbReference type="DOI" id="10.1016/S1096-7192(02)00204-4"/>
</citation>
<scope>VARIANT HP1 ASP-112</scope>
<scope>VARIANT ILE-326</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="7277" last="7282">
<title>Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.</title>
<authorList>
<person name="Santana A."/>
<person name="Salido E."/>
<person name="Torres A."/>
<person name="Shapiro L.J."/>
</authorList>
<dbReference type="PubMed" id="12777626"/>
<dbReference type="DOI" id="10.1073/pnas.1131968100"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT HP1 THR-244</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Kidney Int." volume="66" first="746" last="752">
<title>Clinical implications of mutation analysis in primary hyperoxaluria type 1.</title>
<authorList>
<person name="van Woerden C.S."/>
<person name="Groothoff J.W."/>
<person name="Wijburg F.A."/>
<person name="Annink C."/>
<person name="Wanders R.J.A."/>
<person name="Waterham H.R."/>
</authorList>
<dbReference type="PubMed" id="15253729"/>
<dbReference type="DOI" id="10.1111/j.1523-1755.2004.00796.x"/>
</citation>
<scope>VARIANTS HP1 ARG-82; ILE-152; VAL-153; ARG-170 AND ASP-336</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Am. J. Nephrol." volume="25" first="183" last="188">
<title>Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria.</title>
<authorList>
<person name="Monico C.G."/>
<person name="Olson J.B."/>
<person name="Milliner D.S."/>
</authorList>
<dbReference type="PubMed" id="15849466"/>
<dbReference type="DOI" id="10.1159/000085411"/>
</citation>
<scope>VARIANTS HP1 VAL-139 DEL; ARG-156; LEU-158; ARG-190; GLU-201; LEU-233; THR-244 AND ARG-253</scope>
<scope>VARIANT ASN-9</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="Am. J. Nephrol." volume="25" first="269" last="275">
<title>Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel.</title>
<authorList>
<person name="Frishberg Y."/>
<person name="Rinat C."/>
<person name="Shalata A."/>
<person name="Khatib I."/>
<person name="Feinstein S."/>
<person name="Becker-Cohen R."/>
<person name="Weismann I."/>
<person name="Wanders R.J.A."/>
<person name="Rumsby G."/>
<person name="Roels F."/>
<person name="Mandel H."/>
</authorList>
<dbReference type="PubMed" id="15961946"/>
<dbReference type="DOI" id="10.1159/000086357"/>
</citation>
<scope>VARIANTS HP1 ARG-41; ARG-108; ARG-156; ARG-190; ARG-195; HIS-243; THR-244; MET-279; THR-287; CYS-289 AND PRO-298</scope>
<scope>VARIANT ASN-9</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Mol. Genet. Metab." volume="86" first="172" last="178">
<title>The major allele of the alanine:glyoxylate aminotransferase gene: nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1.</title>
<authorList>
<person name="Coulter-Mackie M.B."/>
<person name="Lian Q."/>
<person name="Applegarth D."/>
<person name="Toone J."/>
</authorList>
<dbReference type="PubMed" id="15963748"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2005.05.005"/>
</citation>
<scope>VARIANTS HP1 ARG-161 AND LEU-218</scope>
<scope>VARIANTS THR-279 AND VAL-280</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Mol. Genet. Metab." volume="89" first="349" last="359">
<title>Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations.</title>
<authorList>
<person name="Coulter-Mackie M.B."/>
<person name="Lian Q."/>
</authorList>
<dbReference type="PubMed" id="16971151"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2006.07.013"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS HP1 ARG-41; VAL-41; GLU-82; ARG-108; ASP-112; ARG-156; ARG-161; ARG-170; TYR-173; ASN-183; PHE-187; PRO-205 AND LEU-218</scope>
<scope>MUTAGENESIS OF LYS-209</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Clin. Chem." volume="53" first="1216" last="1221">
<title>Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1.</title>
<authorList>
<person name="Williams E."/>
<person name="Rumsby G."/>
</authorList>
<dbReference type="PubMed" id="17495019"/>
<dbReference type="DOI" id="10.1373/clinchem.2006.084434"/>
</citation>
<scope>VARIANTS HP1 CYS-36; ARG-41; GLU-41; PRO-150; ILE-152; ARG-156; LEU-158; CYS-161; SER-161; PRO-166; ARG-170; TYR-173; CYS-233; HIS-233; THR-244 AND ARG-253</scope>
<scope>VARIANT ASN-9</scope>
<scope>CHARACTERIZATION OF VARIANTS HP1 CYS-36; GLU-41; PRO-150; ARG-156; LEU-158; CYS-161; SER-161; PRO-166; TYR-173; CYS-233; HIS-233 AND ARG-253</scope>
<scope>CHARACTERIZATION OF VARIANT ASN-9</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="Biochim. Biophys. Acta" volume="1832" first="2277" last="2288">
<title>Gly161 mutations associated with primary hyperoxaluria type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.</title>
<authorList>
<person name="Oppici E."/>
<person name="Roncador A."/>
<person name="Montioli R."/>
<person name="Bianconi S."/>
<person name="Cellini B."/>
</authorList>
<dbReference type="PubMed" id="24055001"/>
<dbReference type="DOI" id="10.1016/j.bbadis.2013.09.002"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS HP1 ARG-161; CYS-161 AND SER-161</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="2475" last="2484">
<title>Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.</title>
<authorList>
<person name="Fargue S."/>
<person name="Lewin J."/>
<person name="Rumsby G."/>
<person name="Danpure C.J."/>
</authorList>
<dbReference type="PubMed" id="23229545"/>
<dbReference type="DOI" id="10.1074/jbc.M112.432617"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS HP1 ARG-41; ILE-152; ARG-170 AND THR-244</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="BMC Nephrol." volume="15" first="92" last="92">
<title>Mutational analysis of AGXT in two Chinese families with primary hyperoxaluria type 1.</title>
<authorList>
<person name="Li G.M."/>
<person name="Xu H."/>
<person name="Shen Q."/>
<person name="Gong Y.N."/>
<person name="Fang X.Y."/>
<person name="Sun L."/>
<person name="Liu H.M."/>
<person name="An Y."/>
</authorList>
<dbReference type="PubMed" id="24934730"/>
<dbReference type="DOI" id="10.1186/1471-2369-15-92"/>
</citation>
<scope>VARIANT HP1 ASN-202</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2015" name="Biochim. Biophys. Acta" volume="1854" first="1280" last="1289">
<title>Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.</title>
<authorList>
<person name="Montioli R."/>
<person name="Oppici E."/>
<person name="Dindo M."/>
<person name="Roncador A."/>
<person name="Gotte G."/>
<person name="Cellini B."/>
<person name="Borri Voltattorni C."/>
</authorList>
<dbReference type="PubMed" id="26149463"/>
<dbReference type="DOI" id="10.1016/j.bbapap.2015.07.002"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT HP1 ARG-47</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="catalytic activity">
<text>L-serine + pyruvate = 3-hydroxypyruvate + L-alanine.</text>
</comment>
<comment type="catalytic activity">
<text>L-alanine + glyoxylate = pyruvate + glycine.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>pyridoxal 5'-phosphate</name>
<dbReference type="ChEBI" id="CHEBI:597326"/>
</cofactor>
</comment>
<comment type="subunit">
<text evidence="12 19 23">Homodimer.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-727098"/>
<interactant intactId="EBI-727098"/>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-727098"/>
<interactant intactId="EBI-15982193">
<id>P50542-1</id>
<label>PEX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="20 23 24 26">Peroxisome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20 23">Mitochondrion</location>
</subcellularLocation>
<text evidence="23">Predominantly localized in the peroxisomes. Mitochondrial mistargeting occurs in variant proteins Arg-41, Arg-47, Ile-152, Arg-170 and Thr-244 associated with the disease HP1.</text>
</comment>
<comment type="tissue specificity">
<text>Liver.</text>
</comment>
<comment type="polymorphism">
<text evidence="20">Polymorphism at position 11 acts synergistically with different mutations in AGXT producing specific enzymic phenotypes in HP1 patients. The combined presence of Leu-11 and Met-340 polymorphisms defines the minor AGXT allele, whereas their absence defines the major allele. The minor allele has frequencies of 20% in normal European and North American populations, and 50% in HP1 patients.</text>
</comment>
<comment type="disease" evidence="5 6 7 8 9 10 11 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29">
<disease id="DI-01778">
<name>Hyperoxaluria primary 1</name>
<acronym>HP1</acronym>
<description>An inborn error of glyoxylate metabolism characterized by increased excretion of oxalate and glycolate, and progressive tissue accumulation of insoluble calcium oxalate. Affected individuals are at risk for nephrolithiasis, nephrocalcinosis and early onset end-stage renal disease.</description>
<dbReference type="MIM" id="259900"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="30">Belongs to the class-V pyridoxal-phosphate-dependent aminotransferase family.</text>
</comment>
<dbReference type="EC" id="2.6.1.51"/>
<dbReference type="EC" id="2.6.1.44"/>
<dbReference type="EMBL" id="X56092">
<property type="protein sequence ID" value="CAA39572.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X53414">
<property type="protein sequence ID" value="CAA37493.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D13368">
<property type="protein sequence ID" value="BAA02632.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M61763">
<property type="protein sequence ID" value="AAA51680.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292754">
<property type="protein sequence ID" value="BAF85443.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC104809">
<property type="protein sequence ID" value="AAY24168.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471063">
<property type="protein sequence ID" value="EAW71222.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132819">
<property type="protein sequence ID" value="AAI32820.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2543.1"/>
<dbReference type="PIR" id="I39419">
<property type="entry name" value="XNHUSP"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000021.1">
<property type="nucleotide sequence ID" value="NM_000030.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.144567"/>
<dbReference type="PDB" id="1H0C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-392"/>
</dbReference>
<dbReference type="PDB" id="1J04">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-392"/>
</dbReference>
<dbReference type="PDB" id="2YOB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=1-388"/>
</dbReference>
<dbReference type="PDB" id="3R9A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/C=1-392"/>
</dbReference>
<dbReference type="PDB" id="4CBR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-392"/>
</dbReference>
<dbReference type="PDB" id="4CBS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-392"/>
</dbReference>
<dbReference type="PDB" id="4I8A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=1-392"/>
</dbReference>
<dbReference type="PDB" id="4KXK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/C=1-392"/>
</dbReference>
<dbReference type="PDB" id="4KYO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/C=1-392"/>
</dbReference>
<dbReference type="PDB" id="5F9S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=6-391"/>
</dbReference>
<dbReference type="PDB" id="5HHY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=6-391"/>
</dbReference>
<dbReference type="PDB" id="5LUC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B/E/G/M/N/S/T=1-392"/>
</dbReference>
<dbReference type="PDB" id="5OFY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1-392"/>
</dbReference>
<dbReference type="PDB" id="5OG0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-392"/>
</dbReference>
<dbReference type="PDBsum" id="1H0C"/>
<dbReference type="PDBsum" id="1J04"/>
<dbReference type="PDBsum" id="2YOB"/>
<dbReference type="PDBsum" id="3R9A"/>
<dbReference type="PDBsum" id="4CBR"/>
<dbReference type="PDBsum" id="4CBS"/>
<dbReference type="PDBsum" id="4I8A"/>
<dbReference type="PDBsum" id="4KXK"/>
<dbReference type="PDBsum" id="4KYO"/>
<dbReference type="PDBsum" id="5F9S"/>
<dbReference type="PDBsum" id="5HHY"/>
<dbReference type="PDBsum" id="5LUC"/>
<dbReference type="PDBsum" id="5OFY"/>
<dbReference type="PDBsum" id="5OG0"/>
<dbReference type="ProteinModelPortal" id="P21549"/>
<dbReference type="SMR" id="P21549"/>
<dbReference type="BioGrid" id="106694">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="DIP" id="DIP-59650N"/>
<dbReference type="IntAct" id="P21549">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="MINT" id="MINT-1419187"/>
<dbReference type="STRING" id="9606.ENSP00000302620"/>
<dbReference type="DrugBank" id="DB08060">
<property type="generic name" value="4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID"/>
</dbReference>
<dbReference type="DrugBank" id="DB02079">
<property type="generic name" value="Aminooxyacetic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00145">
<property type="generic name" value="Glycine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00160">
<property type="generic name" value="L-Alanine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00133">
<property type="generic name" value="L-Serine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04083">
<property type="generic name" value="N'-Pyridoxyl-Lysine-5'-Monophosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00114">
<property type="generic name" value="Pyridoxal Phosphate"/>
</dbReference>
<dbReference type="iPTMnet" id="P21549"/>
<dbReference type="PhosphoSitePlus" id="P21549"/>
<dbReference type="BioMuta" id="AGXT"/>
<dbReference type="DMDM" id="134855"/>
<dbReference type="MaxQB" id="P21549"/>
<dbReference type="PaxDb" id="P21549"/>
<dbReference type="PeptideAtlas" id="P21549"/>
<dbReference type="PRIDE" id="P21549"/>
<dbReference type="Ensembl" id="ENST00000307503">
<property type="protein sequence ID" value="ENSP00000302620"/>
<property type="gene ID" value="ENSG00000172482"/>
</dbReference>
<dbReference type="GeneID" id="189"/>
<dbReference type="KEGG" id="hsa:189"/>
<dbReference type="UCSC" id="uc002waa.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="189"/>
<dbReference type="DisGeNET" id="189"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000172482.4"/>
<dbReference type="GeneCards" id="AGXT"/>
<dbReference type="GeneReviews" id="AGXT"/>
<dbReference type="HGNC" id="HGNC:341">
<property type="gene designation" value="AGXT"/>
</dbReference>
<dbReference type="HPA" id="HPA035370"/>
<dbReference type="HPA" id="HPA035371"/>
<dbReference type="MalaCards" id="AGXT"/>
<dbReference type="MIM" id="259900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604285">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P21549"/>
<dbReference type="OpenTargets" id="ENSG00000172482"/>
<dbReference type="Orphanet" id="93598">
<property type="disease" value="Primary hyperoxaluria type 1"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24633"/>
<dbReference type="eggNOG" id="KOG2862">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0075">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000006648"/>
<dbReference type="HOGENOM" id="HOG000171815"/>
<dbReference type="HOVERGEN" id="HBG006907"/>
<dbReference type="InParanoid" id="P21549"/>
<dbReference type="KO" id="K00830"/>
<dbReference type="OMA" id="WGCDDKP"/>
<dbReference type="OrthoDB" id="EOG091G0EMK"/>
<dbReference type="PhylomeDB" id="P21549"/>
<dbReference type="TreeFam" id="TF313234"/>
<dbReference type="BioCyc" id="MetaCyc:HS10525-MONOMER"/>
<dbReference type="BRENDA" id="2.6.1.44">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389661">
<property type="pathway name" value="Glyoxylate metabolism and glycine degradation"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P21549"/>
<dbReference type="GeneWiki" id="AGXT"/>
<dbReference type="GenomeRNAi" id="189"/>
<dbReference type="PRO" id="PR:P21549"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000172482"/>
<dbReference type="CleanEx" id="HS_AGXT"/>
<dbReference type="Genevisible" id="P21549">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005782">
<property type="term" value="C:peroxisomal matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005777">
<property type="term" value="C:peroxisome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008453">
<property type="term" value="F:alanine-glyoxylate transaminase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016597">
<property type="term" value="F:amino acid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043621">
<property type="term" value="F:protein self-association"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030170">
<property type="term" value="F:pyridoxal phosphate binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004760">
<property type="term" value="F:serine-pyruvate transaminase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008483">
<property type="term" value="F:transaminase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034641">
<property type="term" value="P:cellular nitrogen compound metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019265">
<property type="term" value="P:glycine biosynthetic process, by transamination of glyoxylate"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009436">
<property type="term" value="P:glyoxylate catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046487">
<property type="term" value="P:glyoxylate metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0042853">
<property type="term" value="P:L-alanine catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019448">
<property type="term" value="P:L-cysteine catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046724">
<property type="term" value="P:oxalic acid secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042866">
<property type="term" value="P:pyruvate biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051591">
<property type="term" value="P:response to cAMP"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051384">
<property type="term" value="P:response to glucocorticoid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.640.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.1150.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000192">
<property type="entry name" value="Aminotrans_V_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR020578">
<property type="entry name" value="Aminotrans_V_PyrdxlP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR015424">
<property type="entry name" value="PyrdxlP-dep_Trfase"/>
</dbReference>
<dbReference type="InterPro" id="IPR015421">
<property type="entry name" value="PyrdxlP-dep_Trfase_major_sub1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015422">
<property type="entry name" value="PyrdxlP-dep_Trfase_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR024169">
<property type="entry name" value="SP_NH2Trfase/AEP_transaminase"/>
</dbReference>
<dbReference type="Pfam" id="PF00266">
<property type="entry name" value="Aminotran_5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000524">
<property type="entry name" value="SPT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53383">
<property type="entry name" value="SSF53383"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00595">
<property type="entry name" value="AA_TRANSFER_CLASS_5"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0032">Aminotransferase</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0576">Peroxisome</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0663">Pyridoxal phosphate</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Serine--pyruvate aminotransferase" id="PRO_0000150237">
<location>
<begin position="1"/>
<end position="392"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="360"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="N6-(pyridoxal phosphate)lysine">
<location>
<position position="209"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="4">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="312"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs115014558." id="VAR_060547" evidence="16 17 21">
<original>T</original>
<variation>N</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; reduction of specific alanine--glyoxylate aminotransferase activity in vitro; causes mitochondrial mistargeting when associated with R-170; dbSNP:rs34116584." id="VAR_000587" evidence="9 20">
<original>P</original>
<variation>L</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34885252." id="VAR_048236">
<original>N</original>
<variation>S</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177157." id="VAR_074582" evidence="21">
<original>R</original>
<variation>C</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177168." id="VAR_074583" evidence="21">
<original>G</original>
<variation>E</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of protein stability; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; partial mitochondrial mistargeting; intraperoxisomal protein aggregation seen; dbSNP:rs121908523." id="VAR_000588" evidence="7 9 17 19 21 23 27">
<original>G</original>
<variation>R</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; reduced alanine--glyoxylate aminotransferase activity; no loss of dimerization; no effect on protein stability; dbSNP:rs180177168." id="VAR_010969" evidence="5 6 19">
<original>G</original>
<variation>V</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in protein misfolding; decreased alanine--glyoxylate aminotransferase activity; reduced expression levels; reduced pyridoxal phosphate binding; reduced dimerization; reduced thermostability; increased propensity to aggregation; increased susceptibility to proteolytic degradation within the N-terminal region; mitochondrial mistargeting; exposure to pyridoxine can rescue the functionality by partially preventing aggregation and degradation and by redirecting all the protein to the peroxisome; dbSNP:rs180177173." id="VAR_074584" evidence="26">
<original>G</original>
<variation>R</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; abolishes alanine--glyoxylate aminotransferase activity by interfering with pyridoxal phosphate binding; dbSNP:rs121908522." id="VAR_008878" evidence="9 14 19">
<original>G</original>
<variation>E</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177185." id="VAR_060548" evidence="15">
<original>G</original>
<variation>R</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1." id="VAR_010970" evidence="5 6">
<original>E</original>
<variation>EE</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; decreased protein stability; dbSNP:rs180177197." id="VAR_060549" evidence="17 19 29">
<original>W</original>
<variation>R</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; decreased protein stability; causes protein aggregation; dbSNP:rs796052061." id="VAR_060550" evidence="10 19">
<original>A</original>
<variation>D</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177207." id="VAR_010971" evidence="5 6">
<original>G</original>
<variation>R</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1." id="VAR_060551" evidence="16">
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177222." id="VAR_074585" evidence="21">
<original>L</original>
<variation>P</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in protein destabilization; decreased alanine--glyoxylate aminotransferase activity; no loss of dimerization; mitochondrial mistargeting; dbSNP:rs121908524." id="VAR_000589" evidence="8 9 15 21 23 27">
<original>F</original>
<variation>I</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177223." id="VAR_060552" evidence="15">
<original>L</original>
<variation>V</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; decreased protein stability; dbSNP:rs121908530." id="VAR_010972" evidence="5 6 7 16 17 19 21">
<original>G</original>
<variation>R</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177225." id="VAR_060553" evidence="16 21">
<original>S</original>
<variation>L</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; reduced expression levels; decreased protein stability; protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate; reduced peroxisomal localization; dbSNP:rs180177227." id="VAR_074586" evidence="21 24">
<original>G</original>
<variation>C</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; reduced expression levels; decreased protein stability; protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate; loss of dimerization; dbSNP:rs180177227." id="VAR_060554" evidence="18 19 24">
<original>G</original>
<variation>R</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; reduced expression levels; decreased protein stability; protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate; reduced peroxisomal localization; dbSNP:rs180177227." id="VAR_074587" evidence="21 24">
<original>G</original>
<variation>S</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177230." id="VAR_074588" evidence="21">
<original>L</original>
<variation>P</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in mitochondrial mistargeting; slight decrease in alanine--glyoxylate aminotransferase activity; loss of dimerization; partial loss of protein stability but protein stability increases in the presence of pyridoxal phosphate; causes protein aggregation; dbSNP:rs121908529." id="VAR_000590" evidence="8 9 15 19 20 21 23">
<original>G</original>
<variation>R</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; decreased protein stability; causes protein aggregation; dbSNP:rs180177231." id="VAR_060555" evidence="19 21 29">
<original>C</original>
<variation>Y</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; no loss of dimerization; no effect on protein stability; dbSNP:rs180177236." id="VAR_010973" evidence="8 19">
<original>D</original>
<variation>N</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization but improved dimerization in the presence of pyridoxal phosphate; decreased protein stability; dbSNP:rs180177238." id="VAR_000591" evidence="13 19">
<original>S</original>
<variation>F</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177239." id="VAR_060556" evidence="7 16 17 29">
<original>G</original>
<variation>R</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177244." id="VAR_060557" evidence="17">
<original>M</original>
<variation>R</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177246." id="VAR_060558" evidence="16">
<original>D</original>
<variation>E</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; unknown pathological significance; dbSNP:rs536352238." id="VAR_074589" evidence="25">
<original>I</original>
<variation>N</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; decreased protein stability; dbSNP:rs121908520." id="VAR_000592" evidence="19 22">
<original>S</original>
<variation>P</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; no effect on protein stability; dbSNP:rs180177253." id="VAR_060559" evidence="18 19">
<original>S</original>
<variation>L</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs121908526." id="VAR_008879" evidence="8 21 28">
<original>R</original>
<variation>C</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs121908527." id="VAR_008880" evidence="21 28">
<original>R</original>
<variation>H</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs121908527." id="VAR_060560" evidence="16">
<original>R</original>
<variation>L</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177258." id="VAR_060561" evidence="17">
<original>D</original>
<variation>H</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; prevalent mutation in the Canary islands; when associated with L-11 and M-340 on the minor AGXT allele; results in protein misfolding; decreased alanine--glyoxylate aminotransferase activity; no loss of dimerization; partial mitochondrial mistargeting; dbSNP:rs121908525." id="VAR_008881" evidence="7 8 9 11 16 17 21 23 28">
<original>I</original>
<variation>T</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; when associated with L-11 and M-340 on the minor AGXT allele; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177264." id="VAR_060562" evidence="16 21">
<original>C</original>
<variation>R</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177277." id="VAR_060563" evidence="17">
<original>I</original>
<variation>M</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs140992177." id="VAR_060564" evidence="18">
<original>I</original>
<variation>T</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs73106685." id="VAR_060565" evidence="18">
<original>A</original>
<variation>V</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177289." id="VAR_060566" evidence="17">
<original>S</original>
<variation>T</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177290." id="VAR_060567" evidence="7 17">
<original>R</original>
<variation>C</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13408961." id="VAR_048237">
<original>A</original>
<variation>T</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1." id="VAR_060568" evidence="29">
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177293." id="VAR_060569" evidence="7 17">
<original>L</original>
<variation>P</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs115057148." id="VAR_060570" evidence="10">
<original>V</original>
<variation>I</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177155." id="VAR_060571" evidence="15">
<original>V</original>
<variation>D</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; associated with hyperoxaluria; dbSNP:rs4426527." id="VAR_000593" evidence="20">
<original>I</original>
<variation>M</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="sequence variant" description="In HP1; dbSNP:rs180177156." id="VAR_060572" evidence="29">
<original>G</original>
<variation>D</variation>
<location>
<position position="350"/>
</location>
</feature>
<feature type="mutagenesis site" description="Affects pyridoxal phosphate binding; loss of alanine--glyoxylate aminotransferase activity." evidence="9 19">
<original>K</original>
<variation>R</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="13"/>
<end position="15"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="27"/>
<end position="29"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="35"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="51"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="73"/>
<end position="80"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="82"/>
<end position="93"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="99"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="107"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="122"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="136"/>
<end position="146"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="149"/>
<end position="156"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="158"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="169"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="179"/>
<end position="183"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="185"/>
<end position="190"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="195"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="201"/>
<end position="209"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="218"/>
<end position="222"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="224"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="244"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="254"/>
<end position="256"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="266"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="284"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="308"/>
<end position="311"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="314"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="321"/>
<end position="325"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="332"/>
<end position="343"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="344"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="352"/>
<end position="354"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="355"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="358"/>
<end position="362"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="365"/>
<end position="367"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="370"/>
<end position="386"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KYO"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F9S"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O35423"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10394939"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10453743"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10541294"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10862087"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10960483"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12559847"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12777626"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12899834"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1301173"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1349575"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15253729"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15849466"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15961946"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15963748"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16971151"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1703535"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17495019"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2039493"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23229545"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24055001"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24934730"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26149463"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8101040"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9192270"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9604803"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="392" mass="43010" checksum="2987DDE85B2470B4" modified="1991-05-01" version="1">
MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEI
KEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIG
ARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLL
LVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSF
YLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHG
RLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLR
IGLLGCNATRENVDRVTEALRAALQHCPKKKL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>